Covered recipient · General Payments record
FARZANA QURESHI
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2024
$2,385.40
- Reported across 122 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $415.49 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $109.67 | 4 |
| GlaxoSmithKline, LLC. | $71.57 | 3 |
| Amgen Inc. | $66.05 | 3 |
| PFIZER INC. | $43.34 | 2 |
| Acerta Pharma LLC | $38.58 | 2 |
| Astellas Pharma US Inc | $24.51 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.83 | 1 |
| Sumitomo Pharma America, Inc. | $20.65 | 1 |
| Novo Nordisk AS | $20.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $24.52 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117359256 | CMS |
| Amgen Inc. | $23.97 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117359258 | CMS |
| Amgen Inc. | $17.56 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117359260 | CMS |
| Astellas Pharma US Inc | $24.51 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139267620 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.88 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104680449 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.70 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105313737 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $20.83 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086127410 | CMS |
| GlaxoSmithKline, LLC. | $19.10 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116310021 | CMS |
| GlaxoSmithKline, LLC. | $20.98 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116125796 | CMS |
| GlaxoSmithKline, LLC. | $31.49 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116730910 | CMS |
| Lilly USA, LLC | $28.41 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134975844 | CMS |
| Lilly USA, LLC | $30.66 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134964513 | CMS |
| Lilly USA, LLC | $32.24 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134967001 | CMS |
| Lilly USA, LLC | $18.36 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134975736 | CMS |
| Novo Nordisk Inc | $20.29 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096841656 | CMS |
| PFIZER INC. | $20.13 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131883300 | CMS |
| PFIZER INC. | $23.21 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130884800 | CMS |
| Sumitomo Pharma America, Inc. | $20.65 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148906609 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.